Jun 14 |
7 A-Rated Biotech Stocks Worth Betting on in June
|
Jun 13 |
Teva sues Corcept over mifepristone 'monopoly' for rare disorder
|
Jun 12 |
Teva asthma inhaler patents are 'improperly listed' in FDA Orange Book
|
Jun 11 |
Teva Pharmaceutical Industries Limited (TEVA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
|
Jun 7 |
Teva Pharmaceutical: Buy This Bargain Before It's Gone
|
Jun 4 |
Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
|
Jun 4 |
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
|
Jun 1 |
New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)
|
Jun 1 |
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
|
May 30 |
Teva wins FDA nod for new Austedo formulation
|